Challenges and Opportunities in the Management of Onychomycosis

Onychomycosis is an increasingly common fungal nail infection, chiefly caused by dermatophyte fungi. The disease is notoriously difficult to treat due to the deep-seated nature of fungi within the nail plate, prolonged treatment requirements, poor patient adherence and frequent recurrences. Given the poor efficacy of currently available topical and systemic therapies, there is a renewed interest in exploring alternative treatment modalities for onychomycosis. Natural therapies, physical treatments and various combination therapies have all shown potential for the management of onychomycosis, though research on many of these methods is still in preliminary stages. Further large, well-designed, randomised controlled trials are necessary to confirm the efficacy of these novel treatments in order to make formal recommendations regarding their use in the management of onychomycosis.

[1]  S. Lipner,et al.  Onychomycosis: Treatment and prevention of recurrence. , 2019, Journal of American Academy of Dermatology.

[2]  S. Lipner,et al.  Onychomycosis: Clinical overview and diagnosis. , 2019, Journal of American Academy of Dermatology.

[3]  M. Ghannoum,et al.  Epidemiology of Onychomycosis , 2018 .

[4]  V. Vicente,et al.  Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic , 2018, Front. Microbiol..

[5]  B. Kim,et al.  Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis , 2017, Annals of dermatology.

[6]  L. Ilag,et al.  A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis , 2017, BMC Complementary and Alternative Medicine.

[7]  P. Magin,et al.  Oral antifungal medication for toenail onychomycosis. , 2017, The Cochrane database of systematic reviews.

[8]  S. G. Versteeg,et al.  A critical review of improvement rates for laser therapy used to treat toenail onychomycosis , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  N. Shear,et al.  Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment , 2017, Journal of cutaneous medicine and surgery.

[10]  G. Friedman,et al.  Pilot study to evaluate a plasma device for the treatment of onychomycosis , 2017, Clinical and experimental dermatology.

[11]  Xiuli Wang,et al.  A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis , 2017, Lasers in Medical Science.

[12]  J. Atashili,et al.  Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns , 2016, BMC Research Notes.

[13]  S. Lipner,et al.  Over-the-counter and natural remedies for onychomycosis: do they really work? , 2016, Cutis.

[14]  Xiuli Wang,et al.  Photodynamic therapy for onychomycosis: A systematic review. , 2016, Photodiagnosis and photodynamic therapy.

[15]  B. Elewski,et al.  Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence , 2016, Skin Appendage Disorders.

[16]  Jing Xu,et al.  Self-controlled Study of Onychomycosis Treated with Long-pulsed Nd:YAG 1064-nm Laser Combined with Itraconazole , 2016, Chinese medical journal.

[17]  L. Xi,et al.  Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer , 2016, Lasers in Medical Science.

[18]  M. Cernea,et al.  Improving Cure Rates in Onychomycosis , 2016, Journal of cutaneous medicine and surgery.

[19]  C. Sălăvăstru,et al.  Laser therapies for onychomycosis – critical evaluation of methods and effectiveness , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  Aditya K. Gupta,et al.  The role of biofilms in onychomycosis. , 2016, Journal of the American Academy of Dermatology.

[21]  R. Summerbell,et al.  The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  A. Mostaghimi,et al.  Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis. , 2016, JAMA dermatology.

[23]  N. Önen,et al.  A Novel Treatment for Onychomycosis in People Living With HIV Infection: Vicks VapoRub™ is Effective and Safe , 2016, The Journal of the Association of Nurses in AIDS Care : JANAC.

[24]  B. Elewski,et al.  Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy. , 2015, The Journal of clinical and aesthetic dermatology.

[25]  F. C. Flores,et al.  Essential Oils for Treatment for Onychomycosis: A Mini-Review , 2015, Mycopathologia.

[26]  D. Graves,et al.  Plasma treatment of onychomycosis , 2015 .

[27]  T. Auvinen,et al.  Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator‐blinded, parallel‐group clinical trial , 2015, The British journal of dermatology.

[28]  K. Nouri,et al.  An update on photodynamic therapies in the treatment of onychomycosis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  B. Elewski,et al.  Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. , 2015, Journal of the American Academy of Dermatology.

[30]  Aditya K. Gupta,et al.  Network Meta-Analysis of Onychomycosis Treatments , 2015, Skin Appendage Disorders.

[31]  Do Won Kim,et al.  Increasing Prevalence of Trichophyton rubrum Identified through an Analysis of 115,846 Cases over the Last 37 Years , 2015, Journal of Korean medical science.

[32]  T. Rosen,et al.  Laser Therapy for Onychomycosis: Fact or Fiction? , 2015, Journal of fungi.

[33]  Aditya K. Gupta,et al.  New pharmacotherapy for the treatment of onychomycosis: an update , 2015, Expert opinion on pharmacotherapy.

[34]  Bingrong Zhou,et al.  Combined Oral Terbinafine and Long-Pulsed 1,064-nm Nd: YAG Laser Treatment Is More Effective for Onychomycosis Than Either Treatment Alone , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[35]  I. Bristow.  The effectiveness of lasers in the treatment of onychomycosis: a systematic review , 2014, Journal of Foot and Ankle Research.

[36]  Xiaolin Wang,et al.  Systematic review of severe acute liver injury caused by terbinafine , 2014, International Journal of Clinical Pharmacy.

[37]  Jeung-Hoon Lee,et al.  Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. , 2014, Journal of the American Academy of Dermatology.

[38]  H. Gladstone,et al.  Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial. , 2014, Journal of the American Academy of Dermatology.

[39]  L. Figueiredo Souza,et al.  Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis , 2014, Dermatologic therapy.

[40]  M. Landthaler,et al.  Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment. , 2013, Future microbiology.

[41]  J. Jokinen,et al.  Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study , 2013, Mycoses.

[42]  B. Elewski,et al.  Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. , 2013, Journal of the American Academy of Dermatology.

[43]  F. Harris,et al.  Photodynamic therapy based on 5‐aminolevulinic acid and its use as an antimicrobial Agent , 2012, Medicinal research reviews.

[44]  S. Menéndez,et al.  Therapeutic efficacy of topical OLEOZON® in patients suffering from onychomycosis , 2011, Mycoses.

[45]  P. Rohal,et al.  Novel Treatment of Onychomycosis using Over-the-Counter Mentholated Ointment: A Clinical Case Series , 2011, The Journal of the American Board of Family Medicine.

[46]  Gregory M. Peterson,et al.  Toenail onychomycosis: an important global disease burden , 2010, Journal of clinical pharmacy and therapeutics.

[47]  S. N. Murthy,et al.  Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. , 2009, Journal of pharmaceutical sciences.

[48]  A. Zamilpa,et al.  Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis. , 2009, Journal of ethnopharmacology.

[49]  A. Zamilpa,et al.  Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability of Ageratina pichinchensis Extract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox , 2008, Planta medica.

[50]  J. Szepietowski,et al.  Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. , 2006, Archives of dermatology.

[51]  G. Piérard.  Spores, Sporodochia and Fomites in Onychomycosis , 2006, Dermatology.

[52]  T. Riley,et al.  Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties , 2006, Clinical Microbiology Reviews.

[53]  F. O. Pereira,et al.  Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol. , 2005, Fitoterapia.

[54]  R. Baran,et al.  Onychomycosis in clinical practice: factors contributing to recurrence. , 2003, The British journal of dermatology.

[55]  T. Riley,et al.  In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. , 2002, The Journal of antimicrobial chemotherapy.

[56]  T. Syed,et al.  Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream , 1999, Tropical medicine & international health : TM & IH.

[57]  Buck Ds,et al.  Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. , 1994 .

[58]  R. Scher,et al.  Onychomycosis is more than a cosmetic problem , 1994, The British journal of dermatology.

[59]  D. S. Buck,et al.  Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. , 1994, The Journal of family practice.

[60]  S. Dore.  Onychomycosis , 1929, Proceedings of the Royal Society of Medicine.